References
- Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT 3rd, Moran CJ : Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg 5 : 337-343, 2013 https://doi.org/10.1136/neurintsurg-2012-010334
- Aradi D, Collet JP, Mair J, Plebani M, Merkely B, Jaffe AS, et al. : Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding? Thromb Haemost 113 : 221-230, 2015 https://doi.org/10.1160/TH14-05-0449
- Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, et al. : Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J 36 : 1762-1771, 2015 https://doi.org/10.1093/eurheartj/ehv104
- Asai T, Miyachi S, Izumi T, Matsubara N, Haraguchi K, Yamanouchi T, et al. : Relationship between low response to clopidogrel and periprocedural ischemic events with coil embolization for intracranial aneurysms. J Neurointerv Surg 8 : 752-755, 2016 https://doi.org/10.1136/neurintsurg-2015-011727
- Buch AN, Singh S, Roy P, Javaid A, Smith KA, George CE, et al. : Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention. Am J Cardiol 99 : 1518-1522, 2007 https://doi.org/10.1016/j.amjcard.2007.01.023
- Cattaneo M : Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur Heart J 28 : 1673-1675, 2007 https://doi.org/10.1093/eurheartj/ehm232
- Chalouhi N, Tjoumakaris S, Dumont AS, Gonzalez LF, Randazzo C, Starke RM, et al. : Treatment of posterior circulation aneurysms with the pipeline embolization device. Neurosurgery 72 : 883-889, 2013 https://doi.org/10.1227/NEU.0b013e31828ba984
- Choi HH, Lee JJ, Cho YD, Han MH, Cho WS, Kim JE, et al. : Antiplatelet premedication for stent-assisted coil embolization of intracranial aneurysms: low-dose prasugrel vs clopidogrel. Neurosurgery 83 : 981-988, 2018 https://doi.org/10.1093/neuros/nyx591
- Daou B, Starke RM, Chalouhi N, Barros G, Tjoumakaris S, Rosenwasser RH, et al. : P2Y12 reaction units: effect on hemorrhagic and thromboembolic complications in patients with cerebral aneurysms treated with the pipeline embolization device. Neurosurgery 78 : 27-33, 2016 https://doi.org/10.1227/NEU.0000000000000978
- Delgado Almandoz JE, Crandall BM, Scholz JM, Fease JL, Anderson RE, Kadkhodayan Y, et al. : Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the pipeline embolization device. J Neurointerv Surg 5 Suppl 3 : iii3-iii10, 2013 https://doi.org/10.1136/neurintsurg-2012-010582
- Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, et al. : The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (6 Suppl) : 299S-339S, 2008 https://doi.org/10.1378/chest.08-0675
- Drazin D, Choulakian A, Nuno M, Kornbluth P, Alexander MJ : Body weight: a risk factor for subtherapeutic antithrombotic therapy in neurovascular stenting. J Neurointerv Surg 3 : 177-181, 2011 https://doi.org/10.1136/jnis.2010.004085
- Farid NA, Payne CD, Small DS, Winters KJ, Ernest CS 2nd, Brandt JT, et al. : Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently. Clin Pharmacol Ther 81 : 735-741, 2007 https://doi.org/10.1038/sj.clpt.6100139
- Fifi JT, Brockington C, Narang J, Leesch W, Ewing SL, Bennet H, et al. : Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. AJNR Am J Neuroradiol 34 : 716-720, 2013 https://doi.org/10.3174/ajnr.A3405
- Gaglia MA, Torguson R, Pakala R, Xue Z, Sardi G, Suddath WO, et al. : Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention. J Interv Cardiol 24 : 529-534, 2011 https://doi.org/10.1111/j.1540-8183.2011.00670.x
- Godino C, Mendolicchio L, Figini F, Latib A, Sharp AS, Cosgrave J, et al. : Comparison of VerifyNow-P2Y12 test and flow cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy? Thromb J 7 : 4, 2009 https://doi.org/10.1186/1477-9560-7-4
- Goh C, Churilov L, Mitchell P, Dowling R, Yan B : Clopidogrel hyperresponse and bleeding risk in neurointerventional procedures. AJNR Am J Neuroradiol 34 : 721-726, 2013 https://doi.org/10.3174/ajnr.A3418
- Gross L, Aradi D, Sibbing D : Platelet function testing in patients on antiplatelet medications. Semin Thromb Hemost 42 : 306-320, 2016 https://doi.org/10.1055/s-0035-1570083
- Ha EJ, Cho WS, Kim JE, Cho YD, Choi HH, Kim T, et al. : Prophylactic antiplatelet medication in endovascular treatment of intracranial aneurysms: low-dose prasugrel versus clopidogrel. AJNR Am J Neuroradiol 37 : 2060-2065, 2016 https://doi.org/10.3174/ajnr.A4864
- Hanel RA, Taussky P, Dixon T, Miller DA, Sapin M, Nordeen JD, et al. : Safety and efficacy of ticagrelor for neuroendovascular procedures. A single center initial experience. J Neurointerv Surg 6 : 320-322, 2014 https://doi.org/10.1136/neurintsurg-2013-010699
- Hwang G, Huh W, Lee JS, Villavicencio JB, Villamor RB Jr, Ahn SY, et al. : Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol 72 : 764-772, 2015 https://doi.org/10.1001/jamaneurol.2015.0654
- Kang HS, Kwon BJ, Kim JE, Han MH : Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications. AJNR Am J Neuroradiol 31 : 1206-1210, 2010 https://doi.org/10.3174/ajnr.A2051
- Kashiwazaki D, Kuwayama N, Akioka N, Hayakawa Y, Kuroda S : The roles and issues of P2Y12 percent inhibition assessed by VerifyNow assay for patients undergoing Neurointervention: a prospective study. J Stroke Cerebrovasc Dis 23 : 1830-1836, 2014 https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.04.014
- Kim B, Kim K, Jeon P, Kim S, Kim H, Byun H, et al. : Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. AJNR Am J Neuroradiol 35 : 1786-1792, 2014 https://doi.org/10.3174/ajnr.A3955
- Kim CH, Hwang G, Kwon OK, Ban SP, Chinh ND, Tjahjadi M, et al. : P2Y12 reaction units threshold for implementing modified antiplatelet preparation in coil embolization of unruptured aneurysms: a prospective validation study. Radiology 282 : 542-551, 2017 https://doi.org/10.1148/radiol.2016160542
- Kim MH, Zhang HZ, Jung DK : Pharmacodynamic comparisons for single loading doses of prasugrel (30 mg) and clopidogrel (600 mg) in healthy Korean volunteers. Circ J 77 : 1253-1259, 2013 https://doi.org/10.1253/circj.CJ-12-0783
- Koerner H, Derveaux C, Alexandrou M, Graeber S, Roth C, Papanagiotou P, et al. : Do clopidogrel nonresponders have an increased risk of adverse events during supra-aortal angioplasty and stenting? Stroke Res Treat 2012 : 904534, 2012 https://doi.org/10.1155/2012/904534
- Kovacs EG, Katona E, Bereczky Z, Homorodi N, Balogh L, Toth E, et al. : Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods. Thromb Res 133 : 811-816, 2014 https://doi.org/10.1016/j.thromres.2013.10.008
- Kovacs EG, Katona E, Bereczky Z, Homorodi N, Balogh L, Toth E, et al. : New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals. Thromb Res 131 : 320-324, 2013 https://doi.org/10.1016/j.thromres.2013.01.033
- Lee DH, Arat A, Morsi H, Shaltoni H, Harris JR, Mawad ME : Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol 29 : 1389-1394, 2008 https://doi.org/10.3174/ajnr.A1070
- Lee DH, Kim MH, Guo LZ, Park MK, Yi SJ : Lower loading dose of prasugrel compared with conventional loading doses of clopidogrel and prasugrel in Korean patients undergoing elective coronary angiography: a randomized controlled study evaluating pharmacodynamic efficacy. Korean Circ J 44 : 386-393, 2014 https://doi.org/10.4070/kcj.2014.44.6.386
- Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, et al. : Aspirin resistance: position paper of the working group on aspirin resistance. J Thromb Haemost 3 : 1309-1311, 2005 https://doi.org/10.1111/j.1538-7836.2005.01351.x
- Nishi H, Nakahara I, Matsumoto S, Hashimoto T, Ohta T, Sadamasa N, et al. : Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy. J Neurointerv Surg 8 : 949-953, 2016 https://doi.org/10.1136/neurintsurg-2015-011844
- Nordeen JD, Patel AV, Darracott RM, Johns GS, Taussky P, Tawk RG, et al. : Clopidogrel resistance by P2Y12 platelet function testing in patients undergoing neuroendovascular procedures: incidence of ischemic and hemorrhagic complications. J Vasc Interv Neurol 6 : 26-34, 2013
- Pandya DJ, Fitzsimmons BF, Wolfe TJ, Hussain SI, Lynch JR, Ortega-Gutierrez S, et al. : Measurement of antiplatelet inhibition during neurointerventional procedures: the effect of antithrombotic duration and loading dose. J Neuroimaging 20 : 64-69, 2010 https://doi.org/10.1111/j.1552-6569.2008.00322.x
- Paniccia R, Priora R, Liotta AA, Abbate R : Platelet function tests: a comparative review. Vasc Health Risk Manag 11 : 133-148, 2015 https://doi.org/10.2147/VHRM.S44469
- Pare G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, et al. : Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med 363 : 1704-1714, 2010 https://doi.org/10.1056/NEJMoa1008410
- Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C : Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 : 2373-2383, 2005 https://doi.org/10.1056/NEJMra052717
- Pierot L, Wakhloo AK : Endovascular treatment of intracranial aneurysms: current status. Stroke 44 : 2046-2054, 2013 https://doi.org/10.1161/STROKEAHA.113.000733
- Prabhakaran S, Wells KR, Lee VH, Flaherty CA, Lopes DK : Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 29 : 281-285, 2008 https://doi.org/10.3174/ajnr.A0818
- Scott SA, Sangkuhl K, Shuldiner AR, Hulot JS, Thorn CF, Altman RB, et al. : PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19. Pharmacogenet Genomics 22 : 159-165, 2012 https://doi.org/10.1097/FPC.0b013e32834d4962
- Simon T, Steg PG, Gilard M, Blanchard D, Bonello L, Hanssen M, et al. : Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry. Circulation 123 : 474-482, 2011 https://doi.org/10.1161/CIRCULATIONAHA.110.965640
- Stetler WR, Chaudhary N, Thompson BG, Gemmete JJ, Maher CO, Pandey AS : Prasugrel is effective and safe for neurointerventional procedures. J Neurointerv Surg 5 : 332-336, 2013 https://doi.org/10.1136/neurintsurg-2012-010302
- Tan LA, Keigher KM, Munich SA, Moftakhar R, Lopes DK : Thromboembolic complications with pipeline embolization device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value. J Neurointerv Surg 7 : 217-221, 2015 https://doi.org/10.1136/neurintsurg-2014-011111
- Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, et al. : Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 62 : 2261-2273, 2013 https://doi.org/10.1016/j.jacc.2013.07.101
- Yu KS, Park KW, Kelly RP, Gu N, Payne C, Small DS, et al. : Pharmacokinetic and pharmacodynamic effects of prasugrel in healthy Korean males. J Cardiovasc Pharmacol 62 : 72-77, 2013 https://doi.org/10.1097/FJC.0b013e318290d9e1
Cited by
- Preliminary Experience of Neuroform Atlas Stenting as a Rescue Treatment after Failure of Mechanical Thrombectomy Caused by Residual Intracranial Atherosclerotic Stenosis vol.64, pp.2, 2019, https://doi.org/10.3340/jkns.2020.0146
- Safety of Oral P2Y12 Inhibitors in Interventional Neuroradiology: Current Status and Perspectives vol.42, pp.12, 2021, https://doi.org/10.3174/ajnr.a7303